Lithium is the most commonly used drug for the treatment of manic depressive illness. The precise mechanisms underlying its clinical efficacy remain unknown. We found that long-term exposure to lithium chloride dramatically protects cultured rat cerebellar, cerebral cortical, and hippocampal neurons against glutamate-induced excitotoxicity, which involves apoptosis mediated by N-methyl-Daspartate (NMDA) receptors. This neuroprotection is longlasting, occurs at therapeutically relevant concentrations of lithium with an EC 50 of approximately 1.3 mM, and requires treatment for 6-7 days for complete protection to occur. In contrast, a 24-h treatment with lithium is ineffective. The protection in cerebellar neurons is specific for glutamateinduced excitotoxicity and can be attributed to inhibition of NMDA receptor-mediated calcium inf lux measured by 45 Ca 2؉ uptake studies and fura-2 f luorescence microphotometry. The long-term effects of lithium are not caused by down-regulation of NMDA receptor subunit proteins and are unlikely related to its known ability to block inositol monophosphatase activity. Our results suggest that modulation of glutamate receptor hyperactivity represents at least part of the molecular mechanisms by which lithium alters brain function and exerts its clinical efficacy in the treatment for manic depressive illness. These actions of lithium also suggest that abnormality of glutamatergic neurotransmission as a pathogenic mechanism underlying bipolar illness warrants future investigation.
uptake studies and fura-2 f luorescence microphotometry. The long-term effects of lithium are not caused by down-regulation of NMDA receptor subunit proteins and are unlikely related to its known ability to block inositol monophosphatase activity. Our results suggest that modulation of glutamate receptor hyperactivity represents at least part of the molecular mechanisms by which lithium alters brain function and exerts its clinical efficacy in the treatment for manic depressive illness. These actions of lithium also suggest that abnormality of glutamatergic neurotransmission as a pathogenic mechanism underlying bipolar illness warrants future investigation. Lithium was introduced into psychiatry almost half a century ago and remains the most important drug for the treatment and prophylaxis of mania and depression (1) (2) (3) . It has been estimated that approximately one person per thousand in highly industrialized countries is undergoing lithium therapy. Despite intensive research, the molecular mechanisms underlying the therapeutic actions of lithium are still obscure. Critical to the attribution of any observed biochemical effect to therapeutic relevance is the observation that the action of lithium to stabilize mood cycling of bipolar illness requires a lag period for the efficacy to occur and is not immediately reversed upon discontinuation of treatment (1) (2) (3) . Thus, the mechanisms of action of lithium appears to involve its longterm effects in stabilizing mood in manic depressive patients, perhaps by resetting ion homeostasis or neurotransmitter receptor balance.
Glutamate is a major excitatory amino acid neurotransmitter that plays a prominent role in synaptic plasticity, learning, and memory (4) (5) (6) . Glutamate is also a potent neuronal excitotoxin under a variety of experimental conditions, triggering either rapid or delayed neurotoxicity (7) (8) (9) . Glutamateinduced neuronal death in discrete brain areas has been implicated in neurodegenerative diseases such as Huntington's chorea, Alzheimer's disease, and Parkinsonism (10) (11) (12) . An abnormality in glutamate-dopamine neurotransmission has also been proposed to be the basis of some forms of schizophrenia (13, 14) . In addition, the psychotropic drugs, such as carbamazepine, imipramine, and related tricyclic antidepressants, have been found to have antagonistic properties on the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors (15, 16) . Thus, it seemed logical to investigate the action of lithium on NMDA receptor-mediated response in neurons. In this study, we examined the long-term effects of lithium on NMDA receptor-mediated excitotoxicity in cultured neurons and explored its possible underlying mechanisms.
MATERIALS AND METHODS
Cell Cultures. Cerebellar granule cells were prepared from 8-day-old Sprague-Dawley rats (Taconic Farms) as described (17) . The cells were maintained in basal modified Eagle's medium containing 10% fetal calf serum, 2 mM glutamine, gentamicin (50 g͞ml), and 25 mM KCl. The cells were seeded at a density of 2.7 ϫ 10 5 cells per cm 2 in 24-well plates, 96-well plates, or 100-mm Petri dishes precoated with poly-(L-lysine), depending on the purpose of the experiments. The cells were maintained at 37°C in the presence of 6% CO 2 ͞95% air in a humidified incubator. Cytosine arabinofuranoside (10 M) was added to the cultures approximately 24 h after plating to arrest the growth of nonneuronal cells. The culture medium was not changed until the cerebellar granule cell cultures were used to avoid the neurotoxicity elicited by glutamate present in fresh medium. Routinely, the cultures were pretreated with indicated concentration of LiCl for 6-7 days, starting from days 1 to 2 in vitro. Cells were then exposed to 100 M glutamate for 24 h. Neuron-enriched cerebral cortical and hippocampal cells were prepared from the brains of 17-to 18-day-old Sprague-Dawley rat embryos (Taconic Farms) as described (18) . The cells were maintained in Neurobasal medium (GIBCO͞BRL) containing B-27 serum-free supplement (GIBCO͞BRL). The cells were seeded at a density of 2 ϫ (hippocampal culture) in 96-well plates precoated with poly-(L-lysine) and laminin. The cells were maintained at 37°C in the presence of 6% CO 2 ͞95% air in a humidified incubator. Cultures were used after 9 days in vitro for assessment of glutamate-induced neurotoxicity in the absence or presence of lithium pretreatment.
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0027-8424͞98͞952642-6$0.00͞0 PNAS is available online at http:͞͞www.pnas.org. Measurement of Neurotoxicity. The mitochondrial dehydrogenase activity that cleaves 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) was used to determine cell survival in a quantitative colorimetric assay (19) . The tetrazolium ring of MTT is cleaved by various dehydrogenase enzymes in active mitochondria, forming a blue-colored insoluble product, formazan. Cerebellar granule cells were incubated with MTT (125 g͞ml) added to the growth medium for 1 h at 37°C. The medium was then aspirated and the formazan product was dissolved in dimethyl sulfoxide and quantified spectrophotometrically at 540 nm. The results are expressed as a percentage of control culture viability.
Analysis of DNA Fragmentation. DNA fragmentation was assessed by using a soluble DNA preparation as described (17) . Cerebellar granule cells (2 ϫ 10 7 cells) grown on a 100-mm dish were lysed in 10 mM Tris⅐HCl (pH 7.5) containing 10 mM EDTA and 0.2% Triton X-100. The lysate was centrifuged at 12,000 ϫ g for 10 min. The supernatant was treated with proteinase K (0.3 mg͞ml) and RNase A (0.3 mg͞ml) and then extracted in the presence of NaI. The DNA was precipitated with isopropanol and dissolved in 10 mM Tris⅐HCl (pH 8.0) containing 1 mM EDTA. The DNA was electrophoresed in 1.5% agarose gel in TBE buffer. The DNA bands were then visualized by ethidium bromide-staining and photographed.
Analysis of Chromatin Condensation. Chromatin condensation was detected by nucleus staining with Hoechst 33258 as described (17) . Cerebellar granule cells (2.5 ϫ 10 6 cells) grown on a 35-mm dish were washed with ice-cold PBS and fixed with 4% formaldehyde in PBS. Cells were then stained with Hoechst 33258 (5 g͞ml) for 5 min at 4°C. Nuclei were visualized by using a Zeiss Axiophot fluorescence microscope at ϫ1,000 magnification.
Measurement of Intracellular Free Calcium. Measurement of intracellular free calcium concentration ([Ca 2ϩ ] i ) was carried out as described by using fluorescence microphotometry and the Ca 2ϩ -sensitive indicator fura-2 (15). Cerebellar granule cells (2.5 ϫ 10 6 cells) grown in dishes containing glass bottoms were loaded with 2.5 M fura-2 tetrakis(acetoxymethyl) ester for 30-60 min. The cells were washed three times with an external salt solution (145 mM NaCl͞2.5 mM KCl͞1 mM CaCl 2 ͞10 mM Hepes, pH 7.4͞10 mM glucose) at 37°C. The fura-2 fluorescence was measured by using a SPEX AR-CM fluorescence photometric apparatus and Nikon microscope. Selected clumps of cells were perfused with warmed (37°C) external solution containing 100 M glutamate and 10 M glycine without added LiCl for 10-sec followed by a 60-sec wash. In each dish, four clumps of cells, selected at random, were tested. Within a single experiment, each lithium pretreatment was tested in two dishes. The fura-2 measurements were calibrated by measurements taken in external salts containing 20 M ionomycin, 40 M carbonyl cyanide m-chlorophenylhydrazone, and either 10 mM CaCl 2 (for R max ) or 20 mM EGTA (for R min ). Calcium concentrations were calculated by use of the ratio method, taking 224 nM as the K d value of fura-2 (20) .
Immunoblotting. Cells (2 ϫ 10 7 cells) grown on a 100-mm dish were rinsed with PBS, scraped off the dish, and lysed by boiling in a buffer containing 10 mM Tris (pH 7.4), 1% SDS, and 1 mM sodium orthovanadate. The lysates were centrifuged at 10,000 ϫ g for 5 min and an aliquot containing 20 g of protein was electrophoresed in SDS͞PAGE gels. The proteins were electrophoretically transferred onto a poly(vinylidene difluoride) membrane at 25 V for 2 h. Blots were blocked by incubation for 1 h with 5% nonfat milk in PBS͞0.1% Tween 20 and then incubated with primary antibodies for 1 h at room temperature. The following antibodies were used: anti-NMDAR1 rabbit polyclonal antibodies (Chemicon), anti-NMDAR2A rabbit polyclonal antibodies (Chemicon), anti-NMDAR2B goat polyclonal antibodies (Santa Cruz Biotechnology), and anti-NMDAR2C goat polyclonal antibodies (Santa Cruz Biotechnology). Blots were then incubated with horseradish peroxidase-conjugated secondary antibody. Detection was made by the enhanced chemiluminescence method using ECL Western blotting reagents (Amersham).
RESULTS AND DISCUSSION
Primary cultures of cerebellar granule cells prepared from neonatal rat pups represent a nearly homogenous population of excitatory neurons that are vulnerable to glutamate insult through activation of NMDA receptors (21, 22) . Exposure of rat cerebellar granule cells (cultured for 7-9 days in vitro) to glutamate (100 M) in culture medium for 24 h resulted in the appearance of dead cells, which were round, smaller, and unable to metabolize MTT by mitochondrial dehydrogenases (Fig. 1A) . Preincubation of the cultures with 2 mM LiCl for 7 days markedly protected these neurons against glutamateinduced neurotoxicity, assessed by morphological criteria. Quantification of neuronal survival by MTT metabolism revealed that lithium-induced neuroprotection was associated with a dramatic reduction in the maximal extent of excitotoxicity and appeared to be noncompetitive with respect to glutamate concentration (Fig. 1B) . The degree of protection afforded by lithium was dependent on the length of preincubation time. Maximal protective effect was achieved by preincubation for 6-7 days, whereas a 24-h preincubation failed to elicit any effect (Fig. 1C) . Lithium-induced excitoprotection did not require the continuous presence of this drug. When after 6 days of treatment with LiCl, the drug was removed from cerebellar granule cells by replacement of medium with sisterculture conditioned medium for 24 h, maximal protection from glutamate challenge was still observed (data not shown). The lithium-induced neuroprotection was also concentrationdependent. Although significant protection by lithium was detected at 0.5 mM, the maximal effect was observed at 3 mM with an EC 50 of approximately 1.3 mM (Fig. 1D) . Thus, the protection against excitotoxicity occurs within the therapeutic plasma concentration range of this drug, i.e., 0.5-1.5 mM (23). When glutamate exposure time was prolonged from 24 to 72 h, near complete neuroprotection by lithium was still persistent (Fig. 1E) , indicating a long-lasting effect. Neuron-enriched cerebral cortical and hippocampal cells prepared from embryonic rats also showed lithium-induced protection against excitotoxicity. Glutamate-induced neuronal death in cortical and hippocampal cultures was robustly suppressed by a long-term preincubation (7 days) with 1 mM LiCl (Fig. 1F) , indicating that the neuroprotective effect is not restricted to cerebellar granule cells.
Glutamate-induced delayed neurotoxicity of cerebellar granule cells was associated with the appearance of the hallmarks of apoptosis such as internucleosomal DNA cleavage and chromatin condensation (Fig. 2 A and B) . The internucleosomal cleavage, detected as a DNA ladder on an agarose gel, was completely blocked by the NMDA receptor antagonist dizocilpine (MK-801) and was dose-dependently inhibited by chronic LiCl pretreatment. The remaining DNA fragments smearing on the gel suggest that the necrotic component of glutamate-induced neurotoxicity in cerebellar granule cells (24) was unprotected by lithium pretreatment. Chronic lithium also inhibited glutamate-induced chromatin condensation detected by nuclear staining with Hoechst dye 33258. Although chronic treatment with lithium potently and completely blocked NMDA-induced neurotoxicity of cerebellar granule cells (Fig. 2C) , the toxicity induced by kainate, an agonist of non-NMDA type of glutamate receptors, was only partially protected by chronic lithium even at the highest concentration (5 mM) of this ion examined (Fig. 2C ). Acute treatment with LiCl was ineffective against either excitotoxin. ionophores), veratridine (a Na ϩ channel opener), staurosporine (a protein kinase inhibitor), and sodium nitroprusside (a nitric oxide donor) (Fig. 2D) . Cultured cerebellar granule cells were pretreated with LiCl (2 mM) for 7 days. Cultures were then exposed to glutamate (100 M) and live cells were examined for morphology 24 h later after MTT staining. Cells were photographed with a phase-contrast microscope at a magnification of ϫ200. Note that the glutamate exposure resulted in the typical appearance of dead cells, which were round, smaller, translucent, and unable to metabolize MTT to blue formazan product. Chronic lithium prevented this aspect of glutamate neurotoxicity. (B) The extent of lithium-induced excitoprotection in cerebellar granule neurons at various glutamate concentrations. Cultured cells were pretreated with LiCl (3 mM) for 7 days. Cultures were then exposed to indicated concentrations of glutamate, and neuronal survival was determined 24 h after addition of glutamate by using the MTT colorimetric assay. (C) Preincubation time-dependent excitoprotection elicited by lithium. LiCl (2 mM) was added to cells at various times (0-7 days) before addition of glutamate (100 M) on the 7th day in cultures to vary the time of lithium exposure. Neuronal survival was determined 24 h after addition of glutamate by using the MTT colorimetric assay. The results are expressed as percent of neuroprotection. Note that maximal protection was achieved by pretreatment with lithium for 6 days or longer. (D) Concentration-dependent induction of the excitoprotective state. Cells were pretreated with various concentrations of LiCl (0.1-5 mM) for 6 days and then exposed to 100 M glutamate for 24 h before measurement of neuronal survival by MTT assays. The results are expressed as percent of neuroprotection. (E) Time course of glutamate-induced neurotoxicity. Cultured cerebellar granule cells were pretreated with LiCl (3 mM) for 7 days and then exposed to glutamate (100 M) as indicated. Neuronal survival was determined 24-72 h after addition of glutamate by using the MTT colorimetric assay. (F) Morphology of cultured cerebral cortical and hippocampal neurons exposed to glutamate in the absence and presence of lithium pretreatment. Cultured cortical or hippocampal neurons were pretreated with 1 mM LiCl for 7 days, starting from the second day in culture. Cultures were then exposed to glutamate (100 M), and live cells were examined for morphology 24 h later by MTT staining. Cells were photographed with a phase-contrast microscope at a magnification of ϫ200. Chronic lithium prevented glutamate-induced neurotoxicity. Data are the mean Ϯ SEM of viability measurements from four cultures. ‫,ء‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01; ‫,ءءء‬ P Ͻ 0.001, compared with the group treated with glutamate alone (one-way ANOVA with BonferroniDunn test).
FIG. 2. Effects of chronic lithium pretreatment on neurotoxicity of cerebellar granule cells. (A)
Chronic lithium prevents glutamateinduced internucleosomal DNA fragmentation of cerebellar granule cell. Cells were pretreated with various concentrations of LiCl (3-5 mM) for 7 days and then exposed to glutamate (100 M) as described in Fig. 1 . Soluble DNA was extracted from cells 24 h after the addition of glutamate, subjected to agarose gel electrophoresis, stained with ethidium bromide, and photographed. (B) Chronic lithium inhibits glutamate-induced chromatin condensation of cerebellar granule cell. Cells were pretreated with LiCl (3 mM) for 7 days and then exposed to glutamate (100 M). Chromatin condensation was detected by nucleus staining with Hoechst 33258. Nuclei were photographed with a Zeiss Axiophot fluorescence microscope at a magnification of ϫ1,000. (C) Chronic lithium pretreatment protects cells against NMDA and kainate toxicity. Lithium chloride (0.5-5 mM) was added to cultured neurons 1 h (acute) or 7 days (chronic) before NMDA (1 mM) or kainate (100 M). Additionally MK-801 (1 M) was added to the kainate-treated groups. After 24 h of stimulation, neuronal viability was measured with the MTT colorimetric assay. The results are expressed as percent of neuroprotection. (D) Effects of lithium on A23187, ionomycin, veratridine, staurosporine, and sodium nitroprusside (SNP)-induced neurotoxicity. Lithium chloride (3 mM) was added to cultured cerebellar granule neurons 1 h (acute) or 7 days (chronic) prior to their exposure to A23187 (300 nM), ionomycin (3 M), veratridine (1 M), staurosporine (30 nM), and SNP (100 M). Neuronal survival was determined 24 h after addition by using the MTT colorimetric assay. Data are the mean Ϯ SEM of viability measurements from four or five cultures. ‫,ءء‬ P Ͻ 0.01; ‫,ءءء‬ P Ͻ 0.001, compared with the group of control (one-way ANOVA with Bonferroni-Dunn test). Calcium is a key messenger in glutamate receptor-mediated synaptic plasticity and neurotoxicity (7, 25 influx into cerebellar granule cells and the glutamate-induced increase was inhibited by approximately 50% at all time points by a 7-day pretreatment with LiCl (Fig.  3A) . The inhibition was enhanced by increasing the concentrations of lithium (1-5 mM) during preincubation (Fig. 3B) . In contrast, a 1-h lithium treatment failed to influence glutamate-induced (Fig. 4) . During this short exposure to glutamate, there is little contribution by release from intracellular stores to the calcium increase measured by this method (26) . Similar to the results of (Fig. 5A ) nor the level of immunoreactive NR1, NR2A, or NR2C proteins in these cells (Fig. 5B ) was affected by lithium pretreatment for 7 days. The level of NR2B protein was too low to be detected by immunoblotting in both untreated and lithium-pretreated cells, consistent with a previous report that NR2B mRNA and protein levels are very low in the rat cerebellum throughout development (28) . These results also suggest that lithium-induced suppression of NMDA receptor function is unlikely caused by changes in relative NMDA receptor composition resulting from differential expression of receptor subunit proteins. The neuroprotection could be caused by lithium's ability to block inositol monophosphatase, causing depletion of intracellular inositol. However, the presence of excess (1-10 mM) myo-inositol during lithium preincubation failed to affect neuroprotection against glutamate 45 Ca 2ϩ influx. Cells were treated with LiCl (3 mM) for 7 days before adding 100 M glutamate and 45 CaCl2 (1 Ci͞ml) to the culture medium. At indicated times, the influx was terminated by rapid washing of the culture dishes three times with ice-cold buffer (154 mM choline chloride͞2 mM EGTA͞10 mM Hepes, pH 7.4) and then solubilized in 0.6 ml of 0.5 M NaOH. An aliquot of 0.5 ml was used for measuring 45 Ca 2ϩ radioactivity and the remainder was used for protein determination. (B) Concentration dependence of inhibition by lithium of the 45 Ca 2ϩ influx. Cells were pretreated chronically (7 days) or acutely (1 h) with various concentrations of LiCl (0.1-5 mM) and then exposed to glutamate (100 M) in the presence of 45 excitotoxicity (Fig. 6A) . Moreover, the protective actions against glutamate, NMDA, and kainate insults were not mimicked by L-690,330 (Fig. 6B) , an inositol monophosphatase inhibitor with a potency 1,000 times greater than that of lithium (29) . Additionally, the lithium suppression of glutamate-induced 45 Ca 2ϩ influx was neither affected by myoinositol supplement nor mimicked by L-690,330 (data not shown). Thus, these results suggest that inositol monophosphatase blockade is unlikely to participate in lithium-induced neuroprotection.
Recently, it has been shown that lithium is a potent and selective inhibitor of glycogen synthase kinase 3␤, a highly conserved serine͞threonine kinase implicated in cell-fate determination during development (30) (31) (32) . Lithium inhibition of this kinase mimics the effects of the serine͞threonine kinase Akt on glycogen synthase kinase 3␤ after activation of Akt by receptor tyrosine kinases through phosphatidylinositol 3-kinase (33) . It is conceivable that NMDA receptor subunits are a target for glycogen synthase kinase and that chronic lithium treatment suppresses NMDA receptor function through modulation of the receptor phosphorylation state mediated by this kinase. Alternatively, persistent inhibition of glycogen synthase kinase activity by chronic lithium treatment may enhance gene expression through reduced phosphorylation of c-Jun, causing disinhibition of the DNA binding activity of c-Jun (34) . Although the precise mechanism whereby lithium regulates glutamate-induced Ca 2ϩ homeostasis is unknown, the dose and time requirements of this action of lithium is consistent with the clinical profile of this drug. Our results suggest that modulation of glutamate receptor hyperactivity represents, at least in part, the molecular mechanisms by which lithium exerts its clinical actions in the treatment of manic depressive illness. The possibility that bipolar affective disorder is the result of some abnormality of glutamatergic neurotransmission warrants further investigation.
